Evidence map›Paper›PMID 39076945›Full record

ReviewReviews in cardiovascular medicine2024

Embolic Events in Infective Endocarditis: A Comprehensive Review.

Gonzalo Cabezon, Paloma Pulido, Javier López Díaz, María de Miguel-Álava, Isidre Vilacosta, David García-Azorin, Adrian Lozano, Andrea Oña, Juan Francisco Arenillas, José-Alberto San Román

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gonzalo CabezonInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.
Paloma PulidoInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.
Javier López DíazInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.
María de Miguel-ÁlavaInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.
Isidre VilacostaCiber de Enfermedades Cardiovasculares (CIBER CV), Instituto de investigación Carlos III, 28029 Madrid, Spain.
David García-AzorinServicio de Neurología del Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
Adrian LozanoInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.
Andrea OñaInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.
Juan Francisco ArenillasServicio de Neurología del Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
José-Alberto San RománInstituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infective endocarditis (IE) is a life-threating entity with three main complications: heart failure (HF), uncontrolled infection (UI) and embolic events (EEs). HF and UI are the main indications of cardiac surgery and have been studied thoroughly. On the other hand, much more uncertainty surrounds EEs, which have an abrupt and somewhat unpredictable behaviour. EEs in the setting of IE have unique characteristics that must be explored, such as the potential of hemorrhagic transformation of stroke. Accurately predicting which patients will suffer EEs seems to be pivotal to achieve an optimal management of the disease, but this complex process is still not completely understood. The indication of cardiac surgery in order to prevent EEs in the absence of HF or UI is in question as scientific evidence is controversial and mainly of a retrospective nature. This revision addresses these topics and try to summarize the evidence and recommendations about them.

Indexed as

embolic eventsinfective endocarditismycotic aneurysmstroke

Identifiers

PMID39076945
PMCPMC11263858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.